cannabiol (KL16-012)
/ Knop Laboratorios
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
January 27, 2020
Phase II Clinical Trial, Use of KL16-012 in Women With Fibromyalgia Refractary to Conventional Treatment.
(clinicaltrials.gov)
- P2; N=44; Not yet recruiting; Sponsor: Knop Laboratorios
Clinical • New P2 trial
1 to 1
Of
1
Go to page
1